Hilar cholangiocarcinoma, which accounts for around 2/3 of biliary malignancy, is a challenging condition to treat. Although the majority of patients present with advanced disease, the minority are potentially candidates for surgical resection. This presentation focuses on the work of patients with hillier cholangiocarcinoma with consideration of undergoing surgical resection.
Reducing the abdominal circumference and engaging in core-strengthening exercises are the principals in managing diastasis recti.
The interpretation of liver function tests is a common problem in primary healthcare. A/Professor Adam Bartlett and Dr Marius van Rijnsoever discuss how to interpret abnormal liver function tests and give guidance on which patients require further investigations or treatment. This is a presentation that was given at the General Practice Conference and Medical Exhibition in Rotorua in June 2023.
What is the evidence for lifestyle modification in the management of non-alcoholic fatty liver disease (NAFLD).
Despite being so common there is little guidance regarding the best management for patients with NAFLD. Lifestyle modification remains the cornerstone in management of patients with NAFLD, and involves a multifaceted approach.
People frequently ask whether removal of the gallbladder, known as cholecystectomy, has any long-term consequence.
Until recently, the therapeutic options for patients with advanced hepatocellular carcinoma (HCC) were very limited.
Rarotonga Hospital welcomes ongoing collaboration with visiting surgical team from New Zealand.